DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Gilead Sciences (NASDAQ: GILD)

company name or ticker
Company Photos
(Click to zoom)

While Gilead's Profits Soar, Uncertainty Reigns Supreme At AbbVie

United Therapeutics Lung Drug Keeps Going And Going

Abbvie's Hep C Regimen Approved, Marketing Battle With Gilead Up Next

Cramer: ‘Downside’ to Biotech as ImmunoGen Stock Cut in Half

The 2015 Calendar Of NASH Trial Catalysts IV: GENFIT And Gilead

3 Pharma Giants Growing Significantly Faster Than Pfizer, Inc.

Pfizer is a staple in most retirement and income portfolios, but investors can find stronger growth prospects in each of these three big pharmaceutical stocks.

Jim Cramer's 'Mad Money' Recap: 10 Reasons We'll Have a Santa Claus Rally

Alexion's Rare Disease Model Analyzed

Biogen Idec Poised To Continue Its Stellar Run

Is it Time to Sell Gilead Sciences?

See More Articles...